Meticulous Research® – leading global
market research company is researching on Single-use Bioreactors Market
titled- “Single-use Bioreactors Market by Product (Single-use Bioreactor,
Media Bags), Usage (Lab-scale, Large-scale), Type (Stirred tank,
Bubble-Column), cell type (Mammalian, bacteria), application (Bioproduction,
Research), End user (Pharma & biotech, CROs)- Global Forecast to 2025".
Increase in Government Support for
Biopharmaceutical Research Offers New Growth Avenues for Single-use Bioreactors
Market
Governments in developed as well as
developing nations are offering funding for propagation of biotechnology and
biopharmaceutical research. For instance, in India, in 2017, Department of
Biotechnology (DBT) and World Bank initiated a program - Innovate in India (I3)
- to facilitate research related to the discovery of biopharmaceuticals.
Similarly, in the U.S., National Institute of Health (NIH) collaborated with 11
biopharmaceutical companies to launch the “Partnership for Accelerating Cancer
Therapies (PACT)”, a five-year public-private research collaboration. The aim
of the collaboration is to develop immunotherapy for cancers with total
investment of $215 million. Furthermore, in Korea, the government announced
second Basic Development Plan for Bioengineering (2012). According to which,
the Korean government increased biotech investments to KRW 9.7 trillion ($8.35
billion) through 2016. In addition, Korean government announced the
“Government-Wide Mid- to Long-Term Action Plans to Promote R&D for National
Healthcare” in 2013 - to promote growth of biotechnology and healthcare
industry.
 |
| Single-use Bioreactors Market |
Accessible Exclusive Sample Copy of this Report @
Single-Use Bioreactor Systems Segment
Dominated the Single-Use Bioreactors Market in 2018
Single-use bioreactor system
commanded the largest share of the single-use bioreactors market in 2018 due to
its better flexibility, no sterilization demand, and low operational cost
without compromising the quality of the drug produced. This addresses the
complexities associated with multi‑drug manufacturing processes while providing
maximum savings on the time spent to prepare the bioreactor for the next batch.
Mammalian Cells to Witness the
Largest Demand Through 2025
Mammalian cells commanded the largest
share of single-use bioreactor market in 2018. This is mainly attributed to
proper protein folding, post-translational modifications, and product assembly,
which plays an important role to initiate complete biological activity in
humans.
Asia-Pacific: The Fastest Growing
Regional Market
North America commanded the largest
share of the global single-use bioreactors market in 2018, followed by Europe,
Asia-Pacific, Latin America, and Middle East & Africa. However,
Asia-Pacific is the fastest growing regional market due to accelerated economic
growth of many countries in this region and growing government focus on
pharmaceutical research. In addition, government initiatives to escalate the
drug development process, rising public & private funding for R&D, and
rising contract research and manufacturing activities - are the key factors
propelling the growth of the Asia-Pacific single-use bioreactors market.
Download
free sample report and gain crucial industry insights @
Key players in the Single-use
Bioreactors Market
In the single-use bioreactors market,
the leading players are consistently developing new products with improved
performance, higher efficiency, and low operational costs. In March 2018,
Sartorius Stedim Biotech launched ambr 250 high throughput (ht) perfusion
system for rapid cell culture perfusion process development for production of
therapeutic antibodies. Similarly, in April 2016, Merck Millipore launched
Mobius 1000-liter single-use bioreactor, which has greater flexibility and
continuity for scale-up. Furthermore, in November 2016, Finesse Solutions, Inc.
(U.S.), launched SmartVessel, a single-use 3-liter bioreactor vessel.
The key players operating in the
global single-use bioreactors market are GE Healthcare, Merck Group, Danaher
Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG,
Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO
Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies,
Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors
AG.
Enquire Before Buying:
Contact Info:
Khushal
Contact Sales-
+91-744-7780008
No comments:
Post a Comment